CULTIVATION
Through years of developing cultivation facilities, we’re able to apply our expertise across various continents and cultivate in a variety of formats, from highly-automated indoor grows to multi-hectare outdoor farms. Our cultivation operations are fully diversified to serve both regulated medical markets and rapidly evolving consumer markets, and we’re positioned for the long run with a strong focus on cost-competitiveness.
EXTRACTION + FORMULATIONS
We’ve continued to live up to the MPX reputation for best-in-class cannabis concentrates and extracts. Our proprietary SOPs have been developed to highly sophisticated US standards and are being implemented into our GMP medical production facilities and Swiss extraction laboratory. We utilize high-capacity supercritical C02, as well as ethanol extraction processes, coupled with cutting-edge distillation and formulation equipment.
AWARD-WINNING PRODUCTS
With over 90 medical SKUs and 60 consumer and wellness SKUs, our diverse portfolio of products caters to a wide range of patients and consumers. We actively formulate using 9 different cannabinoids and take pride in ensuring product quality is consistent from market to market.
Latest News
CORPORATE HQ
5255 Yonge Street, Suite 701
Toronto, Ontario
M2N 6P4
Canada
[email protected]
+1 (416) 840-3725
European Consumer HQ
Holyworld SA, MPXI Labs SA & CBDetc
52 Route de Divonne
Nyon 1260
Switzerland